Avery Biomedical Letter to Medscape Regarding Diaphragm Pacing
Please find below a letter that our attorney sent to the editors of Medscape (parent company WebMD) who have published false information about our product.
Medscape Letter Regarding Avery System
Avery Biomedical Devices has an outstanding track record spanning over 45 years including an outstanding safety record, long term viability with some patients pacing for more than 35 years, and exceptional patient satisfaction. It is also the only device of its kind with full FDA premarket approval and CE marking privileges under the European Active Implantable Medical Device Directive, and is approved for both adult and pediatric use.
For more information on the Avery Breathing Pacemaker and the viability of diaphragm pacing, please contact us for more information.